Recent advances in biomarker discovery in solid organ transplant by proteomics

References

• Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N. Engl. J. Med.363(15), 1451–1462 (2010).
   PubMed Web of Science ®Google Scholar
• de Fijter JW. Rejection and function and chronic allograft dysfunction. Kidney Int.78(Suppl. 119), S38–S41 (2010).
   PubMed Web of Science ®Google Scholar
• Turka LA, Lechler RI. Towards the identification of biomarkers of transplantation tolerance. Nat. Rev. Immunol.9(7), 521–526 (2009).
   PubMed Web of Science ®Google Scholar
• Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature470(7333), 204–213 (2011).
   PubMed Web of Science ®Google Scholar
• Ozsolak F, Platt AR, Jones DR et al. Direct RNA sequencing. Nature461(7265), 814–818 (2009).
   PubMed Web of Science ®Google Scholar
• Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature422(6928), 198–207 (2003).
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. Is proteomics the new genomics? Cell130(3), 395–398 (2007).
   PubMed Web of Science ®Google Scholar
• Norden AG, Rodriguez-Cutillas P, Unwin RJ. Clinical urinary peptidomics: learning to walk before we can run. Clin. Chem.53(3), 375–376 (2007).
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24(8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Brouard S, Giral M, Soulillou JP, Ashton-Chess J. Elaboration of gene expression-based clinical decision AIDS for kidney transplantation: where do we stand? Transplantation91(7), 691–696 (2011).
   PubMed Web of Science ®Google Scholar
• Hricik DE, Rodriguez V, Riley J et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am. J. Transplant.3(7), 878–884 (2003).
   PubMed Web of Science ®Google Scholar
• Kowalski RJ, Post DR, Mannon RB et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation82(5), 663–668 (2006).
   PubMed Web of Science ®Google Scholar
• Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med.349(2), 125–138 (2003).
   PubMed Web of Science ®Google Scholar
• Li L, Ying L, Naesens M et al. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol. Genomics32(2), 190–197 (2008).
   PubMed Web of Science ®Google Scholar
• Morgun A, Shulzhenko N, Perez-Diez A et al. Molecular profiling improves diagnoses of rejection and infection in transplanted organs. Circ. Res.98(12), e74–e83 (2006).
   Google Scholar
• Schaub S, Rush D, Wilkins J et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol.15(1), 219–227 (2004).
   PubMed Web of Science ®Google Scholar
• Schaub S, Wilkins JA, Antonovici M et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant.5(4 Pt 1), 729–738 (2005).
   PubMed Web of Science ®Google Scholar
• O’Riordan E, Orlova TN, Mei JJ et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol.15(12), 3240–3248 (2004).
   PubMed Web of Science ®Google Scholar
• Ling XB, Sigdel TK, Lau K et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J. Am. Soc. Nephrol.21(4), 646–653 (2010).
   PubMed Web of Science ®Google Scholar
• Sigdel TK, Kaushal A, Gritsenko M et al. Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin. Appl.4(1), 32–47 (2010).
   PubMed Web of Science ®Google Scholar
• Sigdel TK, Ling XB, Lau K et al. Urinary peptidomic analysis identifies potential biomarkers for acute rejection of renal. Clin. Proteom.5(2), 103–113 (2009).
   Google Scholar
• Sigdel TK, Klassen RB, Sarwal MM. Interpreting the proteome and peptidome in transplantation. Adv. Clin. Chem.47, 139–169 (2009).
   PubMed Web of Science ®Google Scholar
• Sigdel TK, Sarwal MM. The proteogenomic path towards biomarker discovery. Pediatr. Transplant.12(7), 737–747 (2008).
   PubMed Web of Science ®Google Scholar
• Vidal BC, Bonventre JV, I-Hong Hsu S. Towards the application of proteomics in renal disease diagnosis. Clin. Sci. (Lond.)109(5), 421–430 (2005).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Buitrago JM, Ferreira L, Lorenzo I. Urinary proteomics. Clin. Chim. Acta375(1–2), 49–56 (2007).
   PubMed Web of Science ®Google Scholar
• Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation66(5), 562–566 (1998).
   PubMed Web of Science ®Google Scholar
• Simon T, Opelz G, Wiesel M, Ott RC, Susal C. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am. J. Transplant.3(9), 1121–1127 (2003).
   PubMed Web of Science ®Google Scholar
• Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med.344(13), 947–954 (2001).
   PubMed Web of Science ®Google Scholar
• Yannaraki M, Rebibou JM, Ducloux D et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl. Int.19(9), 759–768 (2006).
   PubMed Web of Science ®Google Scholar
• Schaub S, Nickerson P, Rush D et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am. J. Transplant.9(6), 1347–1353 (2009).
   PubMed Web of Science ®Google Scholar
• Camara NO, Silva MS, Nishida S, Pereira AB, Pacheco-Silva A. Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival. Transplantation78(2), 269–275 (2004).
   PubMed Web of Science ®Google Scholar
• Teppo AM, Honkanen E, Finne P, Tornroth T, Gronhagen-Riska C. Increased urinary excretion of alpha1-microglobulin at 6 months after transplantation is associated with urinary excretion of transforming growth factor-beta1 and indicates poor long-term renal outcome. Transplantation78(5), 719–724 (2004).
   PubMed Web of Science ®Google Scholar
• Hollmen ME, Kyllonen LE, Inkinen KA, Lalla ML, Salmela KT. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation. Kidney Int.79(1), 89–98 (2011).
   PubMed Web of Science ®Google Scholar
• Nakorchevsky A, Hewel JA, Kurian SM et al. Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J. Am. Soc. Nephrol.21(2), 362–373 (2010).
   PubMed Web of Science ®Google Scholar
• Chen R, Sigdel TK, Li L et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput. Biol.6(9), e1000940 (2010).
   PubMed Web of Science ®Google Scholar
• Yasui H, Yoshimura N, Kobayashi Y et al. Microstructural changes of bile canaliculi in canine liver: the effect of cold ischemia-reperfusion in orthotopic liver transplantation. Transplant. Proc.30(7), 3754–3757 (1998).
   PubMed Web of Science ®Google Scholar
• Chinese Human Liver Proteome Profiling Consortium. First insight into the human liver proteome from PROTEOME(SKY)-LIVER(Hu) 1.0, a publicly available database. J. Proteome Res.9(1), 79–94 (2010).
   PubMed Web of Science ®Google Scholar
• Mas VR, Maluf DG, Archer KJ, Yanek K, Bornstein K, Fisher RA. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. Transplantation87(1), 143–152 (2009).
   PubMed Web of Science ®Google Scholar
• Emadali A, Muscatelli-Groux B, Delom F et al. Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Mol. Cell. Proteomics5(7), 1300–1313 (2006).
   PubMed Web of Science ®Google Scholar
• Avellini C, Baccarani U, Trevisan G et al. Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver. Transplant. Proc.39(6), 1755–1760 (2007).
   PubMed Web of Science ®Google Scholar
• Vascotto C, Cesaratto L, D’Ambrosio C et al. Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics6(11), 3455–3465 (2006).
   PubMed Web of Science ®Google Scholar
• Hsu LW, Goto S, Nakano T et al. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Transpl. Immunol.17(2), 137–146 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor DO, Stehlik J, Edwards LB et al. Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009. J. Heart Lung Transplant.28(10), 1007–1022 (2009).
   PubMed Web of Science ®Google Scholar
• Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection. Curr. Opin. Cardiol.17(2), 131–136 (2002).
   PubMed Web of Science ®Google Scholar
• Dos Remedios CG, Liew CC, Allen PD, Winslow RL, Van Eyk JE, Dunn MJ. Genomics, proteomics and bioinformatics of human heart failure. J. Muscle Res. Cell. Motil.24(4–6), 251–260 (2003).
   PubMed Web of Science ®Google Scholar
• Meirovich YF, Veinot JP, de Bold ML et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J. Heart Lung Transplant.27(1), 31–37 (2008).
   PubMed Web of Science ®Google Scholar
• Kienzl K, Sarg B, Golderer G et al. Proteomic profiling of acute cardiac allograft rejection. Transplantation88(4), 553–560 (2009).
   PubMed Web of Science ®Google Scholar
• Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J. Heart Lung Transplant.23(5 Suppl.), S187–S193 (2004).
   Web of Science ®Google Scholar
• De Souza AI, Wait R, Mitchell AG, Banner NR, Dunn MJ, Rose ML. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ. Res.97(2), 192–198 (2005).
   PubMed Web of Science ®Google Scholar
• Corbett JM, Why HJ, Wheeler CH et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis19(11), 2031–2042 (1998).
   PubMed Web of Science ®Google Scholar
• Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am. J. Respir. Crit. Care Med.166(4), 440–444 (2002).
   PubMed Web of Science ®Google Scholar
• Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics5(6), 1705–1713 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wroblewski M, Hertz MI, Wendt CH, Cervenka TM, Nelsestuen GL. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics6(3), 1001–1010 (2006).
   PubMed Web of Science ®Google Scholar
• Korfei M, Schmitt S, Ruppert C et al. Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J. Proteome Res.10(5), 2185–2205 (2011).
   PubMed Web of Science ®Google Scholar
• Egidi FM. Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer? Drugs65(2), 153–166 (2005).
   PubMed Web of Science ®Google Scholar
• Sutherland DE, Gruessner RW, Dunn DL et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann. Surg.233(4), 463–501 (2001).
   PubMed Web of Science ®Google Scholar
• Folli F, Guzzi V, Perego L et al. Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients’ skin which are normalized by kidney-pancreas transplantation. PLoS ONE5(3), e9923 (2010).
   PubMed Web of Science ®Google Scholar
• Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol. Cell Proteomics2(10), 1096–1103 (2003).
   PubMed Web of Science ®Google Scholar
• Candiano G, Musante L, Bruschi M et al. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol.17(11), 3139–3148 (2006).
   PubMed Web of Science ®Google Scholar
• Magistroni R, Ligabue G, Lupo V et al. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrol. Dial. Transplant.24(5), 1672–1681 (2009).
   PubMed Web of Science ®Google Scholar
• Musante L, Candiano G, Petretto A et al. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol.18(3), 799–810 (2007).
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, Chutipongtanate S, Kanlaya R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J. Proteome Res.5(1), 183–191 (2006).
   PubMed Web of Science ®Google Scholar
• Sigdel TK, Lau K, Schilling J, Sarwal MM. Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin. Transplant.22(5), 617–623 (2008).
   PubMed Web of Science ®Google Scholar
• Khan A, Packer NH. Simple urinary sample preparation for proteomic analysis. J. Proteome Res.5(10), 2824–2838 (2006).
   PubMed Web of Science ®Google Scholar
• Mischak H, Kolch W, Aivaliotis M et al. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin. Appl.4(4), 464–478 (2010).
   PubMed Web of Science ®Google Scholar
• Engreitz JM, Morgan AA, Dudley JT et al. Content-based microarray search using differential expression profiles. BMC Bioinformatics11, 603 (2010).
   PubMedGoogle Scholar
• Mons B, van Haagen H, Chichester C et al. The value of data. Nat. Genet.43(4), 281–283 (2011).
   PubMed Web of Science ®Google Scholar
• Dudley J, Butte AJ. Enabling integrative genomic analysis of high-impact human diseases through text mining. Pac. Symp. Biocomput.2008, 580–591 (2008).
   Google Scholar
• Basic-Jukic N, Juric I, Kes P, Bubic-Filipi L, Brunetta B, Pasini J. [Arterial hypertension in renal transplant recipients]. Acta Med. Croatica61(2), 171–176 (2007).
   PubMedGoogle Scholar
• Li L, Wadia P, Chen R et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and ‘antibodyome’ measures. Proc. Natl Acad. Sci. USA106(11), 4148–4153 (2009).
   PubMed Web of Science ®Google Scholar
• Millan O, Benitez C, Guillen D et al. Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy. Clin. Immunol.137(3), 337–346 (2010).
   PubMed Web of Science ®Google Scholar
• Kirk AD. Location, location, location: regional immune mechanisms critically influence rejection. Nat. Med.8(6), 553–555 (2002).
   PubMed Web of Science ®Google Scholar
• Ginsburg GS, McCarthy JJ. Personalized medicine: revolutionizing drug discovery and patient care. Trends Biotechnol.19(12), 491–496 (2001).
   PubMed Web of Science ®Google Scholar
• Goldfarb-Rumyantzev AS. Personalized medicine and prediction of outcome in kidney transplant. Am. J. Kidney Dis.56(5), 817–819 (2010).
   PubMed Web of Science ®Google Scholar
• Lampreabe I, Gainza de los Rios FJ, Arrieta Gutierrez A et al. Toward personalized medicine in renal transplantation. Transplant. Proc.42(8), 2864–2867 (2010).
   PubMed Web of Science ®Google Scholar
• Coto E, Tavira B. Pharmacogenetics of calcineurin inhibitors in renal transplantation. Transplantation88(3 Suppl.), S62–S67 (2009).
   PubMed Web of Science ®Google Scholar
• Wavamunno MD, Chapman JR. Individualization of immunosuppression: concepts and rationale. Curr. Opin. Organ Transplant.13(6), 604–608 (2008).
   PubMed Web of Science ®Google Scholar
• Hesselink DA, van Gelder T, van Schaik RH. The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression? Pharmacogenomics6(4), 323–337 (2005).
   PubMed Web of Science ®Google Scholar
• Holt KE, Parkhill J, Mazzoni CJ et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella typhi. Nat. Genet.40(8), 987–993 (2008).
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet.10(1), 57–63 (2009).
   PubMed Web of Science ®Google Scholar
• Butte AJ. Medicine. The ultimate model organism. Science320(5874), 325–327 (2008).
   PubMed Web of Science ®Google Scholar
• Freue GV, Sasaki M, Meredith A et al. Proteomic signatures in plasma during early acute renal allograft rejection. Mol. Cell Proteomics9(9), 1954–1967 (2010).
   PubMed Web of Science ®Google Scholar
• Kurian SM, Heilman R, Mondala TS et al. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS ONE4(7), e6212 (2009).
   Web of Science ®Google Scholar
• Dai Y, Lv T, Wang K, Huang Y, Li D, Liu J. Detection of acute renal allograft rejection by analysis of renal tissue proteomics in rat models of renal transplantation. Saudi J. Kidney Dis. Transpl.19(6), 952–959 (2008).
   PubMedGoogle Scholar
• Jahnukainen T, Malehorn D, Sun M et al. Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J. Am. Soc. Nephrol.17(11), 3248–3256 (2006).
   PubMed Web of Science ®Google Scholar
• Quintana LF, Sole-Gonzalez A, Kalko SG et al. Urine proteomics to detect biomarkers for chronic allograft dysfunction. J. Am. Soc. Nephrol.20(2), 428–435 (2009).
   PubMed Web of Science ®Google Scholar
• Metzger J, Chatzikyrkou C, Broecker V et al. Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis. Proteomics Clin. Appl.5(5–6), 322–333 (2011).
   PubMed Web of Science ®Google Scholar